Clinicopathological characteristics | n | SATB2-AS1 expression | P | |
---|---|---|---|---|
Low expression (n = 66) | High expression (n = 65) | |||
Age (year) | Â | Â | Â | 0.379 |
 ≥ 51 | 55 | 25 | 30 |  |
 < 51 | 76 | 41 | 35 |  |
Menopause | Â | Â | Â | 0.862 |
 No | 61 | 30 | 31 |  |
 Yes | 70 | 36 | 34 |  |
LNM | Â | Â | Â | 0.002 |
 No | 58 | 20 | 38 |  |
 Yes | 73 | 46 | 27 |  |
Tumor diameter | Â | Â | Â | 0.003 |
 < 2 cm | 46 | 15 | 31 |  |
 ≥ 2 cm | 85 | 51 | 34 |  |
TNM stage | Â | Â | Â | 0.008 |
 I–II | 73 | 29 | 44 |  |
 III–IV | 58 | 37 | 21 |  |
Histological grade | Â | Â | Â | 0.138 |
 G1 | 27 | 11 | 16 |  |
 G2 | 68 | 38 | 30 |  |
 G3 | 36 | 17 | 19 |  |
Estrogen receptor | ||||
 + | 58 | 23 | 35 | 0.029 |
 – | 73 | 43 | 30 |  |
Progesterone receptor | ||||
 + | 61 | 24 | 37 | 0.018 |
 – | 70 | 42 | 28 |  |
HER2 status | ||||
 – | 72 | 47 | 35 | 0.337 |
 + | 59 | 29 | 30 |  |